Synovial Sarcoma - Online Support Group

PEN-866 Phase 1/2 Trial


A trial currently recruiting patients is testing a new way to deliver the active metabolite of Irinotecan to tumors:

Irinotecan is often used in pediatric sarcoma but it’s unclear from the medical literature whether it can be effective in synovial sarcoma.